Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A biphenotypic transformation of 8p11 myeloproliferative syndrome with CEP1/FGFR1 fusion gene.
|
16879608 |
2006 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.
|
23171834 |
2013 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
Biomarker
|
disease |
BEFREE |
Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome.
|
17698633 |
2007 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
Biomarker
|
disease |
BEFREE |
Chromosomal translocation of FGFR1 occurs in the 8p11 myeloproliferative syndrome and alveolar rhabdomyosarcoma, as with FGFR3 in multiple myeloma and peripheral T-cell lymphoma.
|
23696246 |
2014 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Diagnostic application of next-generation sequencing in ZMYM2-FGFR1 8p11 myeloproliferative syndrome: A case report.
|
27415155 |
2016 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion.
|
22106025 |
2012 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
Biomarker
|
disease |
BEFREE |
Finally, translocations associated with the rare 8p11 myeloproliferative syndrome and other atypical myeloproliferative disorders have permitted the identification of a number of novel fusion proteins involving fibroblast growth factor receptor-1.
|
11640868 |
2001 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
Biomarker
|
disease |
BEFREE |
Furthermore, TPR-FGFR1 enables cytokine-independent survival, proliferation, and granulocytic differentiation of the interleukin-3 dependent myeloid progenitor cell line 32Dcl3, reflecting the chronic phase of EMS characterized by myeloid hyperplasia.
|
26391436 |
2016 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
Biomarker
|
disease |
BEFREE |
In immunodeficient mice, expression of ZMYM2/FGFR1 or BCR/FGFR1 in human cells induces several features of human EMS, including expansion of several myeloid cell lineages and accumulation of blasts in bone marrow.
|
20554971 |
2010 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In summary, we identified a novel CUX1-FGFR1 fusion oncogene in a patient with the 8p11 myeloproliferative syndrome and demonstrated its transforming potential in the Ba/F3 cell line.
|
21330321 |
2011 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
Biomarker
|
disease |
BEFREE |
In the current World Health Organization classification, the 8p11 myeloproliferative syndrome is designated as "myeloid and lymphoid neoplasms with FGFR1 abnormalities."
|
20226962 |
2010 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
Biomarker
|
disease |
BEFREE |
In the future, FGFR1 inhibitor might be the specific and effective therapeutic target for EMS.
|
21214407 |
2011 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
Biomarker
|
disease |
BEFREE |
In the future, FGFR1 inhibitors might be specific and effective therapeutic targets for EMS.
|
29614500 |
2019 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In the present study, we have investigated a case of EMS harboring a t(8;22)(p11;q11)/BCR-FGFR1 rearrangement as well as a t(9;21)(q34;q22) at the time of AML transformation.
|
17394134 |
2007 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
It is important to recognize that neoplasms carrying the t(8;22)/BCR-FGFR1, although rare, can commonly with B lymphoblastic leukemia at the initial diagnosis, which could distract one from recognizing a possible underlying 8p11 myeloproliferative syndrome.
|
28551329 |
2017 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Of the 2 cases of EMS with t(1;8)(q25;p11.2) which were previously reported, FGFR1 rearrangement was not confirmed in 1 case.
|
25227135 |
2015 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our results further support a critical role of FGFR1 in the pathogenesis of EMS and may lead to more accurate diagnosis and potential targeted therapy.
|
22619110 |
2012 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
Biomarker
|
disease |
BEFREE |
Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.
|
22875613 |
2013 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
Biomarker
|
disease |
BEFREE |
Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib.
|
28881484 |
2017 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The 8p11 myeloproliferative syndrome (EMS) is associated with translocations that disrupt the FGFR1 gene.
|
16946300 |
2006 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The 8p11 myeloproliferative syndrome is a rare hematologic malignancy derived from a pluripotent hematopoietic stem cell associated with rearrangements involving the fibroblast growth factor receptor 1 (FGFR1) gene located on chromosome 8p11.
|
19829149 |
2009 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The 8p11 myeloproliferative syndrome is a rare atypical disorder defined by the presence of rearrangements between the fibroblast growth factor receptor 1 (FGFR1) and 1 of 13 partner genes described to date, including the BCR gene on chromosome 22.
|
23519513 |
2013 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The 8p11 myeloproliferative syndrome is an aggressive neoplasm associated with chromosomal abnormalities involving rearrangement of the fibroblast growth factor receptor 1 (FGFR1) gene.
|
25037443 |
2014 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The 8p11 myeloproliferative syndrome (EMS) is an aggressive chronic myeloproliferative disorder (MPD) that is caused by constitutive activation of fibroblast growth factor receptor 1.
|
25803811 |
2015 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The 8p11 myeloproliferative syndrome (EMS), a rare myeloproliferative disease, generally progresses rapidly and is characterized by chromosomal translocations of the fibroblast growth factor receptor 1 (FGFR1) gene.
|
30116393 |
2018 |